Clinical Trial Update: Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating STM-434 alone or with liposomal doxorubicin in ovarian cancer, fallopian tube cancer, endometrial cancer, and other solid tumors; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Solid Tumors

Drugs mentioned

• STM-434
• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: Santa Maria Biotherapeutics | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 1 | Status: COMPLETED